Impact of medication reconciliation for patients enrolled in oncology early phases clinical trials: A drug-drug interactions retrospective study

被引：1
|
作者：
Malifarge, L. [1 ]
Deppenweiler, M. [1 ]
Italiano, A. [2 ]
Lortal, B. [1 ]
机构：
[1] Inst Bergonie, Pharm, Bordeaux, France
[2] Inst Bergonie, Early Phase Trials Unit, Bordeaux, France
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1489
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1842P
引用
收藏
页码：S1057 / S1057
页数：1
相关论文
共 50 条
  • [31] Drug-drug interactions in patients with acute coronary syndrome across phases of treatment
    Pejcic, Ana V.
    Jankovic, Slobodan M.
    Davidovic, Goran
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (03) : 411 - 422
  • [32] Drug-Drug Interactions in the Red Zone of the Emergency Department: A Retrospective Study
    Antmen, Serife Efsun
    Culha, Canan
    Sancar, Mesut
    Erden Erturk, Sema
    Canacankatan, Necmiye
    Canacankatan, Mehmet
    DUZCE MEDICAL JOURNAL, 2024, 26 (03) : 228 - 233
  • [33] Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
    Noor, Sidra
    Ismail, Mohammad
    Haider, Iqbal
    Khadim, Faiza
    ANNALS OF HEPATOLOGY, 2018, 17 (06) : 1001 - 1011
  • [34] Improving the Working Models for Drug-Drug Interactions: Impact on Preclinical and Clinical Drug Development
    Nguyen, James
    Joseph, David
    Chen, Xin
    Armanios, Beshoy
    Sharma, Ashish
    Stopfer, Peter
    Huang, Fenglei
    PHARMACEUTICS, 2025, 17 (02)
  • [35] Study design considerations to assess the impact of potential drug-drug interactions in first-in-human studies in oncology drug development
    Subramaniam, Sriram
    Shord, Stacy S.
    Leong, Ruby
    Norsworthy, Kelly
    Rahman, Atiqur
    Booth, Brian
    Okusanya, Olanrewaju
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (05): : 719 - 722
  • [36] The impact of treatment choices on potential drug-drug interactions in hypertensive patients
    Peric, Aneta
    Udilovic, Ana
    Dobric, Silva
    Kovacevic, Sandra Vezmar
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (05) : 2340 - 2348
  • [37] Polypharmacy in hematology and oncology patients and the resulting prevalence of potential drug-drug interactions (DDI)
    Metzke, B.
    Fink, G.
    Hieke, S.
    Jung, M.
    Hug, M. J.
    Engelhardt, M.
    ONKOLOGIE, 2012, 35 : 76 - 76
  • [38] Medication use and prevalence of drug-drug interactions in older HIV-positive patients
    Seden, K.
    Bradley, M.
    Miller, A.
    Back, D.
    Khoo, S.
    HIV MEDICINE, 2011, 12 : 77 - 77
  • [39] Drug-Drug Interactions in Hospitalized Cardiac Patients and It's Clinical Management
    Reddy, Kavya
    HYPERTENSION, 2019, 74
  • [40] Drug-Drug Interactions: The Detection and Negative Clinical Consequences in Hospitalized Patients
    Bucsa, C. D.
    Farcas, A. M.
    Cazacu, I.
    Bojita, M. T.
    DRUG SAFETY, 2011, 34 (10) : 992 - 992
12345